Market Overview

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of MGC Diagnostics Corporation And Encourages Shareholders To Contact The Firm For Additional Information


The securities litigation law firm of Brower Piven, A Professional
Corporation, has commenced an investigation into possible breaches of
fiduciary duty and other violations of state law by the Board of
Directors of MGC Diagnostics Corporation (Nasdaq: MGCD) ("MGC
Diagnostics" or the "Company") relating to the proposed buyout of MGC
Diagnostics by Altus Capital Partners, Inc.

Under the terms of the agreement, MGC Diagnostics shareholders are
anticipated to receive $11.03 in cash for each share of MGC Diagnostics
common stock held. The firm's investigation seeks to determine, among
other things, whether the Company's Board of Directors failed to satisfy
their duties to shareholders, including whether the Board adequately
pursued alternatives to the acquisition and whether the Board obtained
the best price possible for the Company's shares of common stock.

If you currently own common stock of MGC Diagnostics and believe that
the proposed buyout price is too low, and you would like to learn more
about the investigation being conducted by Brower Piven, please visit
our website at
You may also request additional information by contacting Brower Piven
either by email at
or by telephone at (410) 415-6616.

Attorneys at Brower Piven have extensive experience in litigating
securities and other class action cases and have been advocating for the
rights of shareholders since the 1980s.

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at